Gynecological Endocrinology

Papers
(The H4-Index of Gynecological Endocrinology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
The follicular levels of adipokines and their ratio as the prognostic markers of in vitro fertilization outcomes36
A case of polycystic ovary syndrome with inevitable miscarriage and multi-site venous thrombosis caused by hereditary protein C deficiency27
Hsa_circ_0020491 promotes polycystic ovary syndrome by interacting with IGF2BP2 through regulation of granular cell autophagy and mitochondrial dysfunction27
Maternal serum midkine level increases in pregnant women with diabetes mellitus: a case-control study25
The in vitro effects of purified and specific cytoplasmic pollen extract on dopaminergic and GABAergic systems24
A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms23
Effect of probiotics combined with metformin on improvement of menstrual and metabolic patterns in women with polycystic ovary syndrome: a randomized clinical trial22
Anti-Müllerian Hormone promotes human osteoblast differentiation and calcification by modulating osteogenic gene expression20
Testosterone in women: beyond hypoactive sexual desire20
Dissecting the causal effects of interleukin receptor-related factors and the risk of developing endometriosis: a two-sample Mendelian randomization study20
The protective effects of S14G-humanin on gestational diabetes mellitus symptoms20
Design and methodology of the ‘endometriosis and pelvic floor dysfunction’ (EndoPFD) multicenter cross-sectional study19
Diagnostic value of anti-Müllerian hormone combined with androgen-levels in Chinese patients with polycystic ovary syndrome19
Is elevated baseline SHBG associated with increased ovulation?18
Clinical efficacy and safety of trimonthly administration of goserelin acetate 10.8 mg in premenopausal Chinese females with symptomatic adenomyosis: a prospective cohort study18
Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial17
Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome17
0.34162712097168